EUVIMEDEUVIMED entdecken
Crossref

L26/P-157 Clinical outcomes of single vitrified-warmed blastocyst transfer using Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF)–containing versus hyaluronan-enriched transfer media: a retrospective comparative study

J. Park, J.W. Lee, H.H. Jung, Y.W. Kim, S.D. Kim, T.H. Min, J.H. Yang, E.S. Lee, J.H. Ahn, J.Y. Chung, S.Y. Kim

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.493 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von J. Park und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does the use of GM-CSF–containing transfer media improve clinical outcomes compared with hyaluronan-enriched transfer media in single vitrified-warmed blastocyst transfer? Summary answer No significant differences were observed in clinical pregnancy and miscarriage rates between GM-CSF–containing and hyaluronan-enriched transfer media in single vitrified-warmed blastocyst transfer cycles. What is known already GM-CSF is a cytokine secreted by epithelial cells of the female reproductive tract and placenta and plays a key role in embryo–maternal communication, as embryos express GM-CSF receptors but cannot synthesize GM-CSF themselves. Previous studies have reported improved reproductive outcomes with GM-CSF–containing media compared with standard media; however, hyaluronan-enriched transfer media are widely used in clinical practice, and direct comparative evidence between these two approaches remains limited. Study design, size, duration This retrospective study evaluated 378 single vitrified-warmed blastocyst transfer cycles in normal responder women aged 22–38 years, conducted from December 2023 to November 2025. All blastocysts were transferred on days 5 or 6 following ovarian stimulation with a GnRH antagonist protocol. Cycles were assigned to either the GM-CSF–containing transfer media group (n = 187) or the hyaluronan-enriched transfer media group (n = 191), depending on the transfer medium used during each period. Participants/materials, setting, methods All blastocysts were graded according to Gardner and Schoolcraft criteria. Cycles involving donor oocytes and double embryo transfer were excluded. Vitrified-warmed blastocysts were equilibrated in the assigned transfer medium under identical conditions for approximately 97 minutes (97.5 ± 25.2 minutes) before embryo transfer. Blastocysts were loaded into a standard embryo transfer catheter. Clinical pregnancy and miscarriage rates were compared between the two groups. Statistical analyses were performed using chi-square tests and independent t-tests. Main results and the role of chance Baseline demographic and cycle characteristics were comparable between the two groups. There were no significant differences in mean female age (33.3 ± 3.0 vs. 33.6 ± 2.7 years, p = 0.36), mean male age (35.5 ± 3.7 vs. 35.7 ± 4.0 years, p = 0.60), number of mature oocytes retrieved (9.9 ± 4.9 vs. 9.8 ± 5.5, p = 0.88), fertilization rate (90.1% vs. 91.2%, p = 0.60), post-warming survival rate (98.9% vs. 99.5%, p = 0.55), and the proportion of transferred good-quality blastocysts (≥BB grade; 48.7% vs. 53.4%, p = 0.36). Clinical outcomes following single vitrified-warmed blastocyst transfer were also similar between the two groups. Biochemical pregnancy rates (72.7% vs. 64.9%, p = 0.10) and ongoing pregnancy rates (61.5% vs. 53.9%, p = 0.14) were numerically higher in the GM-CSF group; however, these differences were not statistically significant and may be attributable to chance. Miscarriage rates were comparable between the two groups (11.2% vs. 11.0%, p = 0.94). As all cycles involved single blastocyst transfer, twin pregnancies were presumed to be monozygotic, with similarly low rates observed in both groups (2.6% vs. 2.9%, p = 0.89). Limitations, reasons for caution This study is limited by its retrospective, single-center design and the absence of live birth data. Inclusion of only normal responder women younger than 38 years may limit generalizability. Potential confounding factors could not be fully accounted for, and subgroup analyses by blastocyst quality were not performed. Wider implications of the findings As an embryo transfer medium supplement, GM-CSF–containing media offer limited additional benefit over hyaluronan-enriched media in young patients with good-quality embryos. Given the higher cost, GM-CSF did not confer clinical advantage in single vitrified-warmed blastocyst transfer, supporting selective rather than routine use and emphasizing the need for prospective evaluation. Trial registration number No

Zitieren

APA

Park, J., Lee, J., Jung, H., Kim, Y., Kim, S., Min, T., Yang, J., Lee, E., Ahn, J., Chung, J., & Kim, S. (2026). L26/P-157 Clinical outcomes of single vitrified-warmed blastocyst transfer using Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF)–containing versus hyaluronan-enriched transfer media: a retrospective comparative study. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.493

Vancouver

Park J, Lee J, Jung H, Kim Y, Kim S, Min T, et al. L26/P-157 Clinical outcomes of single vitrified-warmed blastocyst transfer using Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF)–containing versus hyaluronan-enriched transfer media: a retrospective comparative study. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.493

BibTeX
@article{Park2026,
  author = {Park, J. and Lee, J.W. and Jung, H.H. and Kim, Y.W. and Kim, S.D. and Min, T.H. and Yang, J.H. and Lee, E.S. and Ahn, J.H. and Chung, J.Y. and Kim, S.Y.},
  title = {L26/P-157 Clinical outcomes of single vitrified-warmed blastocyst transfer using Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF)–containing versus hyaluronan-enriched transfer media: a retrospective comparative study},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.493}
}
Kostenlos starten →